HFA Icon

Ackman Has Evidence Of Misleading Allergan Statements, He Just Hasn't Seen It Yet

HFA Padded
Mark Melin
Published on
Updated on
Sign up for our E-mail List and Get FREE Access to Exclusive Investment E-books and More!

Bill Ackman says he has evidence that Allergan, Inc. (NYSE:AGN) officials knowingly delivered false and misleading information to their investors regarding the Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) takeover bid. He just hasn't personally seen the evidence yet.

Ackman Has Evidence Of Misleading Allergan Statements, He Just Hasn't Seen It Yet

Speaking at a conference in Toronto, Ackman told reporters “We believe they put those statements out [and that] they knew they were false at the time that they made them.”

Ackman refers to Allergan's attempt to describe Valeant takeover bid

Ackman is referring to attempts by Allergan, Inc. (NYSE:AGN) to describe the Valeant Pharmaceuticals...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article
Already a member? Log in here
HFA Padded

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.